Birchview Capital’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-80,000
| Closed | -$182K | – | 63 |
|
|
2024
Q2 | $182K | Hold |
80,000
| – | – | 0.17% | 50 |
|
|
2024
Q1 | $346K | Hold |
80,000
| – | – | 0.28% | 42 |
|
|
2023
Q4 | $244K | Sell |
80,000
-40,000
| -33% | -$122K | 0.19% | 46 |
|
|
2023
Q3 | $173K | Buy |
120,000
+80,000
| +200% | +$115K | 0.15% | 47 |
|
|
2023
Q2 | $99.6K | Hold |
40,000
| – | – | 0.07% | 52 |
|
|
2023
Q1 | $107K | Hold |
40,000
| – | – | 0.08% | 51 |
|
|
2022
Q4 | $217K | Hold |
40,000
| – | – | 0.15% | 49 |
|
|
2022
Q3 | $500K | Hold |
40,000
| – | – | 0.35% | 38 |
|
|
2022
Q2 | $198K | Hold |
40,000
| – | – | 0.14% | 52 |
|
|
2022
Q1 | $304K | Hold |
40,000
| – | – | 0.22% | 51 |
|
|
2021
Q4 | $408K | Hold |
40,000
| – | – | 0.26% | 48 |
|
|
2021
Q3 | $537K | Hold |
40,000
| – | – | 0.37% | 38 |
|
|
2021
Q2 | $878K | Hold |
40,000
| – | – | 0.53% | 36 |
|
|
2021
Q1 | $962K | Hold |
40,000
| – | – | 0.57% | 31 |
|
|
2020
Q4 | $720K | Hold |
40,000
| – | – | 0.41% | 34 |
|
|
2020
Q3 | $462K | Hold |
40,000
| – | – | 0.31% | 34 |
|
|
2020
Q2 | $970K | Hold |
40,000
| – | – | 0.59% | 23 |
|
|
2020
Q1 | $441K | Hold |
40,000
| – | – | 0.39% | 31 |
|
|
2019
Q4 | $1.06M | Hold |
40,000
| – | – | 0.77% | 20 |
|
|
2019
Q3 | $911K | Hold |
40,000
| – | – | 0.61% | 15 |
|
|
2019
Q2 | $1.23M | Buy |
40,000
+25,000
| +167% | +$766K | 0.75% | 12 |
|
|
2019
Q1 | $249K | Hold |
15,000
| – | – | 0.16% | 43 |
|
|
2018
Q4 | $287K | Hold |
15,000
| – | – | 0.27% | 39 |
|
|
2018
Q3 | $784K | Sell |
15,000
-7,000
| -32% | -$366K | 0.51% | 21 |
|
|
2018
Q2 | $956K | Hold |
22,000
| – | – | 0.65% | 17 |
|
|
2018
Q1 | $815K | Buy |
+22,000
| New | +$815K | 0.54% | 16 |
|